Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q1 2027 · 10-Q
Revenue$60.14M$60.14M+1.0% vs Q1 2026 Net Income$2.83M$2.83M−40.3% vs Q1 2026 EPS Diluted$0.49$0.49−42.4% vs Q1 2026 Gross Profit$39,012,000+5.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flow$14,736,000+678.4% Free Cash Flowderived$14,177,000+1,503.7% Margins · derivedGross margin64.9%+2.8 pt vs Q1 2026
Operating margin11.7%+6.5 pt vs Q1 2026
Net margin4.7%−3.3 pt vs Q1 2026
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end